The antimalarial drug primaquine targets Fe–S cluster proteins and yeast respiratory growth

Lalève, Anaïs and Vallieres, Cindy and Golinelli-Cohen, Marie-Pierre and Bouton, Cécile and Song, Zehua and Pawlik, Grzegorz and Tindall, Sarah M. and Avery, Simon V. and Clain, Jérôme and Meunier, Brigitte (2016) The antimalarial drug primaquine targets Fe–S cluster proteins and yeast respiratory growth. Redox Biology, 7 . pp. 21-29. ISSN 2213-2317

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution Non-commercial No Derivatives.
Download (763kB) | Preview

Abstract

Malaria is a major health burden in tropical and subtropical countries. The antimalarial drug primaquine is extremely useful for killing the transmissible gametocyte forms of Plasmodium falciparum and the hepatic quiescent forms of P. vivax. Yet its mechanism of action is still poorly understood. In this study, we used the yeast Saccharomyces cerevisiae model to help uncover the mode of action of primaquine. We found that the growth inhibitory effect of primaquine was restricted to cells that relied on respiratory function to proliferate and that deletion of SOD2 encoding the mitochondrial superoxide dismutase severely increased its effect, which can be countered by the overexpression of AIM32 and MCR1 encoding mitochondrial enzymes involved in the response to oxidative stress. This indicated that ROS produced by respiratory activity had a key role in primaquine-induced growth defect. We observed that Δsod2 cells treated with primaquine displayed a severely decreased activity of aconitase that contains a Fe–S cluster notoriously sensitive to oxidative damage. We also showed that in vitro exposure to primaquine impaired the activity of purified aconitase and accelerated the turnover of the Fe–S cluster of the essential protein Rli1. It is suggested that ROS-labile Fe–S groups are the primary targets of primaquine. Aconitase activity is known to be essential at certain life-cycle stages of the malaria parasite. Thus primaquine-induced damage of its labile Fe–S cluster – and of other ROS-sensitive enzymes – could inhibit parasite development.

Item Type: Article
Keywords: Mitochondria; Malaria; Aconitase; Sod2; Oxidative stress; Yeast model; Primaquine
Schools/Departments: University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Life Sciences
Identification Number: https://doi.org/10.1016/j.redox.2015.10.008
Depositing User: Eprints, Support
Date Deposited: 06 Feb 2017 12:07
Last Modified: 07 Feb 2017 15:33
URI: http://eprints.nottingham.ac.uk/id/eprint/40346

Actions (Archive Staff Only)

Edit View Edit View